Vedantra Pharmaceuticals, Inc. — Form D
Vedantra Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-15. The offering totals $30.0M, of which $6.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-07-15
- Form: D
- Accession: 0001567619-20-013296
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $30.0M
- Amount sold: $6.1M
- Remaining: $23.9M
- Investors: 49
- Date of first sale: 2020-06-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-371058
Issuer
- Name: Vedantra Pharmaceuticals, Inc.
- CIK: 0001555192
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: ONE BROADWAY, CAMBRIDGE, MA, 02142
- Phone: 617-360-9995
Officers, directors & promoters (25)
| Name | Role | Location |
|---|
| Isaac Kohlberg | Director | Cambridge, MA |
| Yekaterina Chudnovsky | Director | LOS ANGELES, CA |
| Christopher Haqq | Executive Officer | Boston, MA |
| Carol Ashe | Director | Boston, MA |
| Robert Connelly | Director | Boston, MA |
| Robert Connelly | Executive Officer | Boston, MA |
| Robert Ruffolo | Director | Boston, MA |
| Julian Adams | Director | Boston, MA |
| Julian Adams | Executive Officer | Boston, MA |
| Daniel Behr | Director | Westborough, MA |
| Annette Matthies | Executive Officer | Boston, MA |
| Assaf Segal | Director | Boston, MA |
| Daniel Geffken | Director | Boston, MA |
| Daniel Geffken | Executive Officer | Boston, MA |
| Daphne Karydas | Director | Brooklyn, NY |
| Ofer Gonen | Director | Yavne, L3 |
| Frank Haluska | Director | Cambridge, MA |
| Isaac Blech | Director | Jupiter, FL |
| William Koster | Director | Westborough, MA |
| Satish Jindal | Director | Cleveland, OH |
| Ben Bronstein | Director | Westborough, MA |
| Alan Shaw | Director | Cambridge, MA |
| Alan Shaw | Executive Officer | Cambridge, MA |
| Alan Shaw | Promoter | Cambridge, MA |
| Steve Deitcher | Director | Cambridge, MA |
Other filings by this issuer (12)
More